Literature DB >> 25078551

Comparative evaluation of 5-15-kDa salivary proteins from patients with different oral diseases by MALDI-TOF/TOF mass spectrometry.

Ponlatham Chaiyarit1, Suwimol Taweechaisupapong, Janthima Jaresitthikunchai, Narumon Phaonakrop, Sittiruk Roytrakul.   

Abstract

OBJECTIVES: The present study aimed to determine the potential use of matrix-assisted laser desorption/ionization with time-of-flight/time-of-flight mass spectrometry (MALDI-TOF/TOF MS) for analyzing specific patterns of mass signals of low-molecular-weight proteins in saliva from patients with different oral diseases.
MATERIALS AND METHODS: Unstimulated whole saliva samples were collected from healthy subjects (n = 30) and patients with oral diseases including oral cancer (n = 30), oral lichen planus (n = 30), and chronic periodontitis (n = 30). Proteomic profiles of 5,000-15,000-Da salivary proteins were evaluated by MALDI-TOF/TOF MS. Quantification of mass signals was performed by FlexAnalysis and ClinProTool software.
RESULTS: In oral cancer, the percentages of mass signals at 5,592.26 and 8,301.46 Da were significantly increased as compared with other groups (p = 0.002 and p = 0.030, respectively). In oral lichen planus, the percentages of mass signals at 12,964.55 and 13,279.08 Da were significantly increased as compared with other groups (p < 0.001, and p < 0.001, respectively). In chronic periodontitis, the percentages of mass signals at 5,835.73 and 9,801.83 Da were significantly decreased as compared with other groups (p = 0.003 and p = 0.005, respectively).
CONCLUSIONS: The present study demonstrated a potential use of MALDI-TOF/TOF as a rapid screening method to differentiate one oral disease from others by identifying specific patterns of mass signals in saliva from patients. However, MALDI-TOF/TOF has several limitations regarding the identification of the candidate mass signals. CLINICAL RELEVANCE: MALDI-TOF/TOF MS can be used as a rapid screening method to differentiate one oral disease from others with a caution concerning peptide identity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078551     DOI: 10.1007/s00784-014-1293-3

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  38 in total

1.  Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications.

Authors:  E H van der Meij; I van der Waal
Journal:  J Oral Pathol Med       Date:  2003-10       Impact factor: 4.253

Review 2.  Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management.

Authors:  Isaäc van der Waal
Journal:  Oral Oncol       Date:  2010-03-21       Impact factor: 5.337

3.  Two-dimensional electrophoresis study of in vitro pellicle formation and dental caries susceptibility.

Authors:  Rui Vitorino; Sofia de Morais Guedes; Rita Ferreira; Maria João C Lobo; José Duarte; António J Ferrer-Correia; Kenneth B Tomer; Pedro M Domingues; Francisco M L Amado
Journal:  Eur J Oral Sci       Date:  2006-04       Impact factor: 2.612

4.  Comparative analysis of whole saliva proteomes for the screening of biomarkers for oral lichen planus.

Authors:  L-L Yang; X-Q Liu; W Liu; B Cheng; M-T Li
Journal:  Inflamm Res       Date:  2006-10       Impact factor: 4.575

Review 5.  Is charge reduction in ESI really necessary?

Authors:  Lloyd M Smith
Journal:  J Am Soc Mass Spectrom       Date:  2008-02-23       Impact factor: 3.109

6.  Alterations in the salivary proteome associated with periodontitis.

Authors:  Brendan J Haigh; Kevin W Stewart; John R K Whelan; Matthew P G Barnett; Grant A Smolenski; Thomas T Wheeler
Journal:  J Clin Periodontol       Date:  2010-03       Impact factor: 8.728

7.  Salivary diagnostics: oral health and beyond!

Authors:  W V Giannobile; D T W Wong
Journal:  J Dent Res       Date:  2011-10       Impact factor: 6.116

8.  Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model.

Authors:  Baharak Vafadar-Isfahani; Stephanie Anne-Sophie Laversin; Murrium Ahmad; Graham Ball; Clare Coveney; Christophe Lemetre; Amanda Kathleen Miles; Gerhard van Schalkwyk; Robert Rees; Balwir Matharoo-Ball
Journal:  Proteomics Clin Appl       Date:  2010-09       Impact factor: 3.494

9.  Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome.

Authors:  Shen Hu; Jianghua Wang; Jiska Meijer; Sonya Ieong; Yongming Xie; Tianwei Yu; Hui Zhou; Sharon Henry; Arjan Vissink; Justin Pijpe; Cees Kallenberg; David Elashoff; Joseph A Loo; David T Wong
Journal:  Arthritis Rheum       Date:  2007-11

10.  Different proteomic protein patterns in saliva of Sjögren's syndrome patients.

Authors:  Y Fleissig; O Deutsch; E Reichenberg; M Redlich; B Zaks; A Palmon; D J Aframian
Journal:  Oral Dis       Date:  2008-10-09       Impact factor: 3.511

View more
  11 in total

1.  New detection method in experimental mice for schistosomiasis: ClinProTool and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Yuzheng Huang; Wei Li; Kun Liu; Chunrong Xiong; Peng Cao; Jianping Tao
Journal:  Parasitol Res       Date:  2016-07-29       Impact factor: 2.289

2.  Putative salivary protein biomarkers for the diagnosis of oral lichen planus: a case-control study.

Authors:  Sineepat Talungchit; Waranun Buajeeb; Chotima Lerdtripop; Rudee Surarit; Kongthawat Chairatvit; Sittiruk Roytrakul; Hiroaki Kobayashi; Yuichi Izumi; Siribang-On Piboonniyom Khovidhunkit
Journal:  BMC Oral Health       Date:  2018-03-13       Impact factor: 2.757

3.  Rapid diagnosis of periodontitis, a feasibility study using MALDI-TOF mass spectrometry.

Authors:  Angéline Antezack; Hervé Chaudet; Hervé Tissot-Dupont; Philippe Brouqui; Virginie Monnet-Corti
Journal:  PLoS One       Date:  2020-03-13       Impact factor: 3.240

Review 4.  Proteome Analysis of Molecular Events in Oral Pathogenesis and Virus: A Review with a Particular Focus on Periodontitis.

Authors:  Sachio Tsuchida
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

5.  A Study of the Variation in the Salivary Peptide Profiles of Young Healthy Adults Acquired Using MALDI-TOF MS.

Authors:  Andrei Prodan; Henk Brand; Sultan Imangaliyev; Evgeni Tsivtsivadze; Fridus van der Weijden; Ad de Jong; Armand Paauw; Wim Crielaard; Bart Keijser; Enno Veerman
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

6.  Proteomic analysis of canine oral tumor tissues using MALDI-TOF mass spectrometry and in-gel digestion coupled with mass spectrometry (GeLC MS/MS) approaches.

Authors:  Sirinun Pisamai; Sittiruk Roytrakul; Narumon Phaonakrop; Janthima Jaresitthikunchai; Gunnaporn Suriyaphol
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

Review 7.  Definitions used for a healthy periodontium-A systematic review.

Authors:  An Li; Renske Z Thomas; Luc van der Sluis; Geerten-Has Tjakkes; Dagmar Else Slot
Journal:  Int J Dent Hyg       Date:  2020-05-24       Impact factor: 2.477

8.  In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors.

Authors:  Sekkarin Ploypetch; Sittiruk Roytrakul; Narumon Phaonakrop; Suthathip Kittisenachai; Kantinan Leetanasaksakul; Sirinun Pisamai; Chanin Kalpravidh; Anudep Rungsipipat; Gunnaporn Suriyaphol
Journal:  BMC Vet Res       Date:  2020-09-14       Impact factor: 2.741

9.  Proteomic profiles of unilateral cryptorchidism in pigs at different ages using MALDI-TOF mass spectrometry and in-gel digestion coupled with mass spectrometry (GeLC-MS/MS) approaches.

Authors:  Nathamon Yimpring; Sittiruk Roytrakul; Janthima Jaresitthikunchai; Narumon Phaonakrop; Sucheewin Krobthong; Gunnaporn Suriyaphol
Journal:  BMC Vet Res       Date:  2020-10-02       Impact factor: 2.741

Review 10.  MALDI-TOF/MS Analysis of Non-Invasive Human Urine and Saliva Samples for the Identification of New Cancer Biomarkers.

Authors:  Carlo Zambonin; Antonella Aresta
Journal:  Molecules       Date:  2022-03-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.